Newcourt Acquisition Corp is a blank check company incorporated on February 25, 2021 as a Cayman Islands company for the purpose of effecting a merger, capital exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Report as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to the initial public offering and searching for a potential target for the initial business combination.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
15-12G
Securities registration termination
5 Feb 24
8-K
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
31 Jan 24
25-NSE
Exchange delisting
26 Jan 24
8-K
Entry into a Material Definitive Agreement
24 Jan 24
425
Business combination disclosure
23 Jan 24
8-K
Newcourt Acquisition Corp Announces Continuation
23 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
22 Jan 24
8-K
Other Events
22 Jan 24
425
Business combination disclosure
22 Jan 24
Latest ownership filings
SC 13G/A
GLAZER CAPITAL, LLC
14 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13D/A
Newcourt SPAC Sponsor LLC
16 Jan 24
4
Marc Gregory Balkin
16 Jan 24
4
Change in insider ownership
17 Jul 23
3
de Vyver Jurgen Johannes van
22 Jun 23
3/A
Initial statement of insider ownership (amended)
8 Mar 23
4
Change in insider ownership
8 Mar 23
3
Initial statement of insider ownership
23 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
15 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 88.17 k | 88.17 k | 88.17 k | 88.17 k | 88.17 k | |
Cash burn (monthly) | (no burn) | 10.56 k | 185.68 k | 195.96 k | 45.85 k | |
Cash used (since last report) | n/a | 125.74 k | 2.21 mm | 2.33 mm | 545.77 k | |
Cash remaining | n/a | -37.56 k | -2.12 mm | -2.24 mm | -457.60 k | |
Runway (months of cash) | n/a | -3.6 | -11.4 | -11.5 | -10.0 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 47 |
Opened positions | 4 |
Closed positions | 5 |
Increased positions | 3 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 12.94 bn |
Total shares | 18.82 mm |
Total puts | 0.00 |
Total calls | 108.00 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Newcourt SPAC Sponsor | 7.46 mm | $76.64 mm |
Integrated Core Strategies | 1.66 mm | $0.00 |
EHP Funds | 1.23 mm | $29.34 mm |
Polar Asset Management Partners | 933.00 k | $2.27 bn |
Periscope Capital | 817.73 k | $856.54 mm |
Shaolin Capital Management | 686.34 k | $1.39 mm |
MMCAP International Inc. SPC | 600.00 k | $16.32 mm |
LMR Partners | 600.00 k | $4.51 bn |
Cantor Fitzgerald, L. P. | 562.00 k | $1.88 bn |
Calamos Advisors | 500.00 k | $13.80 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 24 | Marc Gregory Balkin | Class A Ordinary Shares, par value $0.0001 | Other | Acquire J | Yes | No | 0 | 7,455,000 | 0.00 | 7,455,000 |
10 Jan 24 | Marc Gregory Balkin | Private Warrants Ordinary Shares | Other | Acquire J | Yes | No | 11.5 | 460,000 | 5.29 mm | 460,000 |
11 Jul 23 | Polar Asset Management Partners | Class A ordinary shares, par value $0.0001 per share, includ | Other | Dispose J | Yes | No | 11.07 | 130,000 | 1.44 mm | 200,000 |
News
Psyence Biomed Enters Into $25M Common Stock Purchase Agreement With White Lion Capital
31 Jul 24
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
25 Jul 24
Why Psyence Biomedical (PBM) Stock Is Skyrocketing
25 Jul 24
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
25 Jul 24
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
25 Jul 24